Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Breast Cancer

Free Subscription Articles published in Clin Breast Cancer Retrieve available abstracts of 285 articles: HTML format

Single Articles

April 2023
1. WONG DJ, Gandomkar Z, Lewis S, Reed W, et al
   Do Reader Characteristics Affect Diagnostic Efficacy in Screening Mammography? A Systematic Review.
   Clin Breast Cancer. 2023;23:e56-e67.
   PubMed     Abstract available
   
   
   
2. SHAH C, Fleming-Hall E, Asha W
   Update on Accelerated Whole Breast Irradiation.
   Clin Breast Cancer. 2023;23:237-240.
   PubMed     Abstract available
   
   
   
3. PAGLIARA D, Schiavone L, Garganese G, Bove S, et al
   Predicting Mastectomy Skin Flap Necrosis: A Systematic Review of Preoperative and Intraoperative Assessment Techniques.
   Clin Breast Cancer. 2023;23:249-254.
   PubMed     Abstract available
   
   
   
4. STOCCO C, Cazzato V, Renzi N, Manara M, et al
   Central Mound Technique in Oncoplastic Surgery: A Valuable Technique to Save Your Bacon.
   Clin Breast Cancer. 2023;23:e77-e84.
   PubMed     Abstract available
   
   
   
5. LORETI A, Fanelli B, Abate O, Spallone D, et al
   Surgical Delay of Nipple Areola Complex: A Powerful Technique to Extend the Indication of Nipple-Sparing Mastectomy.
   Clin Breast Cancer. 2023;23:255-264.
   PubMed     Abstract available
   
   
   
6. OLERU OO, Akhavan AA, Seyidova N, Ibelli T, et al
   Did the National Ban on Bacitracin Irrigation Affect Infection Rates in Implant-Based Breast Reconstruction? An Analysis of a National Database.
   Clin Breast Cancer. 2023;23:e103-e108.
   PubMed     Abstract available
   
   
   
7. WANG Y, Tang L, Chen P, Chen M, et al
   The Role of a Deep Learning-Based Computer-Aided Diagnosis System and Elastography in Reducing Unnecessary Breast Lesion Biopsies.
   Clin Breast Cancer. 2023;23:e112-e121.
   PubMed     Abstract available
   
   
   
8. BARNI S, Fabi A, Petrelli F
   Lobular Carcinoma of the Breast and Utility of Oncotype Dx(R): a Retrospective Decision Impact Analysis.
   Clin Breast Cancer. 2023;23:e173-e174.
   PubMed     Abstract available
   
   
   February 2023
9. CHAI BS, Ingledew PA
   Characteristics Assessment of Online YouTube Videos on Radiotherapy for Breast Cancer.
   Clin Breast Cancer. 2023 Feb 24:S1526-8209(23)00041.
   PubMed     Abstract available
   
   
   
10. PAN J, Peng L, Xia C, Wang A, et al
    Survival Nomogram for Patients With Locally Advanced Breast Cancer Undergoing Immediate Breast Reconstruction: A SEER Population-Based Study.
    Clin Breast Cancer. 2023 Feb 21:S1526-8209(23)00038.
    PubMed     Abstract available
    
    
    
11. WANG L, Zhao L, Zhang Y, Shao S, et al
    Comprehensive Analysis of the Expression and Prognosis of chromobox Family Members in Breast Cancer.
    Clin Breast Cancer. 2023 Feb 15:S1526-8209(23)00036.
    PubMed     Abstract available
    
    
    
12. YAN K, Gao Y, Heller SL
    Breast Cancer Screening Utilization and Outcomes in Women With Neurofibromatosis Type 1.
    Clin Breast Cancer. 2023 Feb 12:S1526-8209(23)00035.
    PubMed     Abstract available
    
    
    
13. WANG M, Ding Q, Gu J, Sfamenos SM, et al
    Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?
    Clin Breast Cancer. 2023 Feb 12:S1526-8209(23)00037.
    PubMed     Abstract available
    
    
    
14. YANG R, Dong C, Jiang T, Zhang X, et al
    Indocyanine Green and Methylene Blue Dye Guided Sentinel Lymph Node Biopsy in Early Breast Cancer: A Single-Center Retrospective Survival Study in 1574 Patients.
    Clin Breast Cancer. 2023 Feb 11:S1526-8209(23)00032.
    PubMed     Abstract available
    
    
    
15. DU J, Wu K
    PCDHA1 High Expression is Associated With Poor Prognosis and Correlated With Immune Cell Infiltration in Breast Cancer.
    Clin Breast Cancer. 2023 Feb 10:S1526-8209(23)00031.
    PubMed     Abstract available
    
    
    
16. TANG ZN, Bi XF, Chen WL, Zhang CL, et al
    RANKL Promotes Chemotherapy Resistance in Breast Cancer Cells Through STAT3 Mediated Autophagy Induction.
    Clin Breast Cancer. 2023 Feb 7:S1526-8209(23)00030.
    PubMed     Abstract available
    
    
    
17. ZHANG M, Ma N, Wang R
    Mendelian Randomization Study on Causal Association of IL-6With Breast Cancer.
    Clin Breast Cancer. 2023 Feb 5:S1526-8209(23)00029.
    PubMed     Abstract available
    
    
    
18. BARI S, Li J, Kang D, Jameel Z, et al
    A Real-World Data Retrospective Cohort Study of HER2-positive, Early-Stage Breast Cancer in Patients 70 Years of Age or Older: Natural History, Treatment Patterns, and Outcomes.
    Clin Breast Cancer. 2023 Feb 4:S1526-8209(23)00028.
    PubMed     Abstract available
    
    
    
19. PAGLIARA D, Montella RA, Garganese G, Bove S, et al
    Improving Decision-making in Prepectoral Direct-to-implant Reconstruction After Nipple Sparing Mastectomy: The Key Role of Flap Thickness Ratio.
    Clin Breast Cancer. 2023;23:e37-e44.
    PubMed     Abstract available
    
    
    
20. HA M, Ngaage LM, Finkelstein ER, Klein M, et al
    Insurance Coverage of Prophylactic Mastectomies: A National Review of the United States.
    Clin Breast Cancer. 2023;23:211-218.
    PubMed     Abstract available
    
    
    
21. LERNER G, Tang H, Singh K, Golestani R, et al
    AMACR Expression is a Potential Diagnostic Marker in Apocrine Lesions of Breast, and is Associated with High Histologic Grade and Lymph Node Metastases in Some Invasive Apocrine Breast Cancers.
    Clin Breast Cancer. 2023;23:199-210.
    PubMed     Abstract available
    
    
    
22. BENTLEY H, Roberts J, Hayes M, Wilson C, et al
    The Role of Imaging in the Diagnosis of Primary and Secondary Breast Angiosarcoma: Twenty-Five-Year Experience of a Provincial Cancer Institution.
    Clin Breast Cancer. 2023;23:e45-e53.
    PubMed     Abstract available
    
    
    
23. MADAN V, Mamounas EP
    Is Sentinel Lymph Node Biopsy Necessary in Patients who Undergo Prophylactic Mastectomy?
    Clin Breast Cancer. 2023;23:231-236.
    PubMed     Abstract available
    
    
    
24. SAYAN M, Kilic S, Zhang Y, Liu B, et al
    Early Toxicity and Patient-Reported Cosmetic Outcomes in Patients Treated With Adjuvant Proton-Based Radiotherapy After Breast-Conserving Surgery.
    Clin Breast Cancer. 2023;23:176-180.
    PubMed     Abstract available
    
    
    
25. WARD KA, Muller DA, Dutta SW, Malhi J, et al
    Long-Term Adherence to Adjuvant Endocrine Therapy Following Various Radiotherapy Modalities in Early Stage Hormone Receptor Positive Breast Cancer.
    Clin Breast Cancer. 2023 Feb 1:S1526-8209(23)00027.
    PubMed     Abstract available
    
    
    January 2023
26. ALTUNDAG K
    Is Taxane Rechallenge Time Dependent in Patients With Advanced Triple-Negative Breast Cancer?
    Clin Breast Cancer. 2023 Jan 25:S1526-8209(23)00020.
    PubMed    
    
    
    
27. FUENTES-ABOLAFIO IJ, Roldan-Jimenez C, Campos MI, Pajares-Hachero BI, et al
    Forearm Muscle Activity During the Handgrip Test in Breast Cancer Survivors: A Cross-Sectional Study.
    Clin Breast Cancer. 2023 Jan 20:S1526-8209(23)00018.
    PubMed     Abstract available
    
    
    
28. RAZETI MG, Soldato D, Arecco L, Levaggi A, et al
    Approaches to Fertility Preservation for Young Women With Breast Cancer.
    Clin Breast Cancer. 2023 Jan 14:S1526-8209(23)00006.
    PubMed     Abstract available
    
    
    
29. MIYAMOTO N, Inoue H, Inui T, Sasa S, et al
    Absolute Lymphocyte Count Changes During Neoadjuvant Chemotherapy are Associated With Prognosis of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Patients.
    Clin Breast Cancer. 2023 Jan 12:S1526-8209(23)00005.
    PubMed     Abstract available
    
    
    
30. ZHOU HL, Chen DD
    Prognosis of Patients With Triple-negative Breast Cancer: A Population-based Study From SEER Database.
    Clin Breast Cancer. 2023 Jan 11:S1526-8209(23)00001.
    PubMed     Abstract available
    
    
    
31. ADACHI K, Kimura F, Takahashi H, Kaise H, et al
    Delayed Diagnosis and Prognostic Impact of Breast Cancer During the COVID-19 Pandemic.
    Clin Breast Cancer. 2023 Jan 10:S1526-8209(23)00002.
    PubMed     Abstract available
    
    
    
32. SURENDRAN AM, Rai A, Rakshit S, George M, et al
    Immunomodulatory Role of Diospyros peregrina Fruit Preparation in Breast Cancer by Utilizing Macrophage Mediated Antigen Presentation and T Helper Cell (Th) Differentiation.
    Clin Breast Cancer. 2023 Jan 6:S1526-8209(22)00311.
    PubMed     Abstract available
    
    
    
33. CO M, Lam L, Suen D, Kwong A, et al
    Axillary Reverse Mapping in the Prevention of Lymphoedema: A Systematic Review and Pooled Analysis.
    Clin Breast Cancer. 2023;23:e14-e19.
    PubMed     Abstract available
    
    
    
34. FOSKO NK, Gribkova Y, Krupa K, Bs KJ, et al
    The Use of Intraoperative Ultrasound During Breast Conserving Surgery.
    Clin Breast Cancer. 2023;23:54-59.
    PubMed     Abstract available
    
    
    December 2022
35. ALMAWI WY, Zidi S, Sghaier I, El-Ghali RM, et al
    Novel Association of IGF2BP2 Gene Variants With Altered Risk of Breast Cancer and as Potential Molecular Biomarker of Triple Negative Breast Cancer.
    Clin Breast Cancer. 2022 Dec 30:S1526-8209(22)00308.
    PubMed     Abstract available
    
    
    
36. DE OLIVEIRA LM, Garcia HO, Curvello KD, Rebelatto TF, et al
    Letter to the Editor of Clinical Breast Cancer, on "Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review," Conducted by Michelle Bradbury and Collaborators and Published in Clin
    Clin Breast Cancer. 2022 Dec 28:S1526-8209(22)00309.
    PubMed    
    
    
    
37. PENG C, Wu K, Chen X, Lang H, et al
    Migraine and Risk of Breast Cancer: A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2022 Dec 25:S1526-8209(22)00289.
    PubMed     Abstract available
    
    
    
38. ZHANG Z, Li F, Li Y, Li Z, et al
    In vitro Anti-malignant Property of PCMT1 Silencing and Identification of the SNHG16/miR-195/PCMT1 Regulatory Axis in Breast Cancer Cells.
    Clin Breast Cancer. 2022 Dec 24:S1526-8209(22)00291.
    PubMed     Abstract available
    
    
    
39. SUN L, Chen S, Wang T, Bi S, et al
    Hsa_circ_0008673 Promotes Breast Cancer Progression by MiR-578/GINS4 Axis.
    Clin Breast Cancer. 2022 Dec 23:S1526-8209(22)00292.
    PubMed     Abstract available
    
    
    
40. YANG C, Wang M, Huang R, Ou L, et al
    Circ_0108942 Regulates the Progression of Breast Cancer by Regulating the MiR-1178-3p/TMED3 Axis.
    Clin Breast Cancer. 2022 Dec 23:S1526-8209(22)00293.
    PubMed     Abstract available
    
    
    
41. LEWINSOHN R, Zheng Y, Rosenberg SM, Ruddy KJ, et al
    Fertility Preferences and Practices Among Young Women With Breast Cancer: Germline Genetic Carriers Versus Noncarriers.
    Clin Breast Cancer. 2022 Dec 22:S1526-8209(22)00290.
    PubMed     Abstract available
    
    
    
42. HAN Y, Fu Y, Shi Q, Liu H, et al
    The ALDH2, IGSF9, and PRDM16 Proteins as Predictive Biomarkers for Prognosis in Breast Cancer.
    Clin Breast Cancer. 2022 Dec 21:S1526-8209(22)00287.
    PubMed     Abstract available
    
    
    
43. EL-KHAZRAGY N, Gaballah A, Bakkar A, Hemida EHA, et al
    PTEN rs701848 Polymorphism is Associated with Trastuzumab Resistance in HER2-positive Metastatic Breast Cancer and Predicts Progression-free Survival.
    Clin Breast Cancer. 2022 Dec 20:S1526-8209(22)00288.
    PubMed     Abstract available
    
    
    
44. LOBEFARO R, Mariani L, Peverelli G, Ligorio F, et al
    Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison.
    Clin Breast Cancer. 2022 Dec 17:S1526-8209(22)00286.
    PubMed     Abstract available
    
    
    
45. CHEN JH, Canner JK, Myers K, Camp M, et al
    Concomitant Use of Biopsy Clips and Wire Localization in Invasive Breast Cancer is Associated With Successful Clip Retrieval.
    Clin Breast Cancer. 2022 Dec 16:S1526-8209(22)00285.
    PubMed     Abstract available
    
    
    
46. SHAH AN, Santa-Maria CA, Mukhija D, Shah N, et al
    A Phase II Single-arm Study of Palbociclib in Patients With HER2-positive Breast Cancer With Brain Metastases and Analysis of ctDNA in Patients With Active Brain Metastases.
    Clin Breast Cancer. 2022 Dec 15:S1526-8209(22)00283.
    PubMed     Abstract available
    
    
    
47. KOMENAKA IK, Hsu CH, Ramos GM, Nodora J, et al
    Post Treatment Mastalgia is a Common Complaint but not an Indication of Recurrence or Second Primary Breast Cancer.
    Clin Breast Cancer. 2022 Dec 14:S1526-8209(22)00282.
    PubMed     Abstract available
    
    
    
48. BIABANI ARDAKANI J, Abedi SM, Mardanshahi A, Shojaee L, et al
    Molecular Imaging of HER2 Expression in Breast Cancer patients Using the [(99m)Tc] Tc-Labeled Small Peptide.
    Clin Breast Cancer. 2022 Dec 9:S1526-8209(22)00270.
    PubMed     Abstract available
    
    
    
49. CATANEO JL, Meidl H, Ore AS, Raicu A, et al
    The Impact of Limited Language Proficiency in Screening for Breast Cancer.
    Clin Breast Cancer. 2022 Dec 6:S1526-8209(22)00264.
    PubMed     Abstract available
    
    
    
50. YANG B, Wang YW, Qian LH, Xu Y, et al
    Downregulated miR-367-3p, miR-548aq-5p, and miR-4710 in Human Whole Blood: Potential Biomarkers for Breast Cancer With Axillary Lymph Node Metastasis.
    Clin Breast Cancer. 2022 Dec 5:S1526-8209(22)00267.
    PubMed     Abstract available
    
    
    
51. DAVEY MG, Keelan S, Lowery AJ, Kerin MJ, et al
    The Impact of Chemotherapy Prescription on Long-Term Survival Outcomes in Early-Stage Invasive Lobular Carcinoma - A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2022;22:e843-e849.
    PubMed     Abstract available
    
    
    
52. HUGHES RT, Ip EH, Urbanic JJ, Hu JJ, et al
    Smoking and Radiation-induced Skin Injury: Analysis of a Multiracial, Multiethnic Prospective Clinical Trial.
    Clin Breast Cancer. 2022;22:762-770.
    PubMed     Abstract available
    
    
    
53. BRORSON F, Elander A, Thorarinsson A, Hansson E, et al
    Patient Reported Outcome and Quality of Life After Delayed Breast Reconstruction - An RCT Comparing Different Reconstructive Methods in Radiated and Non-radiated Patients.
    Clin Breast Cancer. 2022;22:753-761.
    PubMed     Abstract available
    
    
    
54. HENG SSL, Gan YH, Yahya MM, Haron J, et al
    Changes in Spinal Alignment of Women Who Underwent Unilateral Mastectomy with Immediate Autologous Breast Reconstruction Compared To Mastectomy without Breast Reconstruction.
    Clin Breast Cancer. 2022;22:e863-e873.
    PubMed     Abstract available
    
    
    
55. GOTLAND N, Loya A, Lanng C, Ronning H, et al
    Radiation Induced Atypical Vascular Lesion in the Breast.
    Clin Breast Cancer. 2022;22:e874-e876.
    PubMed     Abstract available
    
    
    
56. ACAR E, Esendagli G, Yazici O, Dursun A, et al
    Tumor-Infiltrating Lymphocytes (TIL), Tertiary Lymphoid Structures (TLS), and Expression of PD-1, TIM-3, LAG-3 on TIL in Invasive and In Situ Ductal Breast Carcinomas and Their Relationship with Prognostic Factors.
    Clin Breast Cancer. 2022;22:e901-e915.
    PubMed     Abstract available
    
    
    
57. SELFRIDGE JM, Sinner HF, Whiting J, Sun W, et al
    Effect of Microporous Polysaccharide Particles in Patients Undergoing Mastectomy.
    Clin Breast Cancer. 2022;22:e922-e927.
    PubMed     Abstract available
    
    
    
58. DUDLEY CM, Stankowski TJ, Tucholka JL, Schumacher JR, et al
    Perspectives of Wisconsin Providers on Factors Influencing Receipt of Post-Mastectomy Breast Reconstruction.
    Clin Breast Cancer. 2022;22:840-846.
    PubMed     Abstract available
    
    
    
59. RUAN D, Sun L
    Diagnostic Performance of PET/MRI in Breast Cancer: A Systematic Review and Bayesian Bivariate Meta-analysis.
    Clin Breast Cancer. 2022 Dec 1:S1526-8209(22)00266.
    PubMed     Abstract available
    
    
    November 2022
60. LI J, Gao R, Zhang J
    USP22 Contributes to Chemoresistance, Stemness, and EMT Phenotype of Triple-Negative Breast Cancer Cells by egulating the Warburg Effect via c-Myc Deubiquitination.
    Clin Breast Cancer. 2022 Nov 25:S1526-8209(22)00262.
    PubMed     Abstract available
    
    
    
61. CHOUCAIR K, Page SJ, Mattar BI, Dakhil CS, et al
    Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-World Experience.
    Clin Breast Cancer. 2022 Nov 23:S1526-8209(22)00261.
    PubMed     Abstract available
    
    
    
62. CHEN Z, Gong X, Cheng C, Fu Y, et al
    Circ_0001777 Affects Triple-negative Breast Cancer Progression Through the miR-95-3p/AKAP12 Axis.
    Clin Breast Cancer. 2022 Nov 19:S1526-8209(22)00249.
    PubMed     Abstract available
    
    
    
63. BARCO I, Chabrera C, Garcia-Fernandez A, Fraile M, et al
    COVID-19 Incidence and Mortality in Patients Operated on for Breast Cancer. Comparison with the General Population.
    Clin Breast Cancer. 2022 Nov 17:S1526-8209(22)00247.
    PubMed     Abstract available
    
    
    
64. MENESES AFP, Pimentel FF, da Cruz JPF, Candido Dos Reis FJ, et al
    Experiences of Women With Breast Cancer Using Telehealth: A Qualitative Systematic Review.
    Clin Breast Cancer. 2022 Nov 12:S1526-8209(22)00246.
    PubMed     Abstract available
    
    
    
65. MISER-SALIHOGLU E, Demokan S, Karanlik H, Karahalil B, et al
    Investigation of mRNA Expression Levels of Tip60 and Related DNA Repair Genes in Molecular Subtypes of Breast Cancer.
    Clin Breast Cancer. 2022 Nov 12:S1526-8209(22)00235.
    PubMed     Abstract available
    
    
    October 2022
66. LIU X, Tao L, Wang M, Li H, et al
    ABSDELL Model: Development and Internal Validation of a Risk Prediction Model of LVEF Decline in Breast Cancer Patients Treated With Trastuzumab.
    Clin Breast Cancer. 2022 Oct 23. pii: S1526-8209(22)00234.
    PubMed     Abstract available
    
    
    
67. TORRES-BALANZA S, Fuentes-Aparicio L, Mena-Del Horno S, Martinez-Aspas A, et al
    Sexual Perception in Spanish Female Breast Cancer Survivors. Cross-Sectional Survey.
    Clin Breast Cancer. 2022 Oct 21. pii: S1526-8209(22)00233.
    PubMed     Abstract available
    
    
    
68. LI ZH, Hong WJ, Guo XL, Li XR, et al
    Serratus Plane Block in Breast Cancer Surgery: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2022 Oct 19. pii: S1526-8209(22)00231.
    PubMed     Abstract available
    
    
    
69. ZHENG H, Yang L, Hu J, Yang Y, et al
    Frequency and Influencing Factors of Shared Decision Making Among Breast Cancer Patients Receiving Surgery: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2022 Oct 18. pii: S1526-8209(22)00230.
    PubMed     Abstract available
    
    
    
70. KIM YE, Cha JH, Kim HH, Shin HJ, et al
    The Accuracy of Mammography, Ultrasound, and Magnetic Resonance Imaging For the Measurement of Invasive Breast Cancer With Extensive Intraductal Components.
    Clin Breast Cancer. 2022 Oct 13. pii: S1526-8209(22)00227.
    PubMed     Abstract available
    
    
    
71. ALDRICH J, Ekpo P, Rupji M, Switchenko JM, et al
    Racial Disparities in Clinical Outcomes on Investigator-Initiated Breast Cancer Clinical Trials at an Urban Medical Center.
    Clin Breast Cancer. 2022 Oct 13. pii: S1526-8209(22)00229.
    PubMed     Abstract available
    
    
    
72. MARTIN S, Pflumio C, Trensz P, Schaff-Wendling F, et al
    Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the COVID-19 Outbreak.
    Clin Breast Cancer. 2022 Oct 13:S1526-8209(22)00228.
    PubMed     Abstract available
    
    
    
73. PURSWANI JM, Nwankwo C, Adotama P, Gutierrez D, et al
    Radiation-induced skin changes after breast or chest wall irradiation in patients with breast cancer and skin of color: a systematic review.
    Clin Breast Cancer. 2022 Oct 8. pii: S1526-8209(22)00225.
    PubMed     Abstract available
    
    
    
74. MEDIONI J, Scimeca D, Marquez YL, Leray E, et al
    Benefits of Homeopathic Complementary Treatment in Patients With Breast Cancer: A Retrospective Cohort Study Based on the French Nationwide Healthcare Database.
    Clin Breast Cancer. 2022 Oct 8. pii: S1526-8209(22)00224.
    PubMed     Abstract available
    
    
    
75. ROY N, Villavisanis DF, Taub PJ
    Mitigating Financial Toxicity in Breast Cancer From Diagnosis to Treatment and Reconstruction.
    Clin Breast Cancer. 2022 Oct 4. pii: S1526-8209(22)00223.
    PubMed     Abstract available
    
    
    
76. CARMON E, Alster T, Maly B, Kadouri L, et al
    Preoperative MRI for Evaluation of Extent of Disease in IDC Compared to ILC.
    Clin Breast Cancer. 2022;22:e745-e752.
    PubMed     Abstract available
    
    
    
77. VIGGIANO T, Scott R, Sharpe R, Kasper C, et al
    Contrast Enhanced Mammography in Routine Clinical Practice: Frequency and Malignancy Rates of Enhancing Otherwise Occult Findings.
    Clin Breast Cancer. 2022;22:e736-e744.
    PubMed     Abstract available
    
    
    
78. OSMAN MH, Rabie NA, Elmehrath AO, Bedair HM, et al
    Primary and Secondary Breast Sarcoma: Clinical and Pathological Characteristics, Prognostic Factors, and Nomograms for Predicting Survival.
    Clin Breast Cancer. 2022;22:e753-e763.
    PubMed     Abstract available
    
    
    
79. GORDON PB
    Clinical Breast Examination is Important in Surveillance After Mastectomy.
    Clin Breast Cancer. 2022;22:e728.
    PubMed    
    
    
    
80. FEI F, Siegal GP, Wei S
    Characterizing Clinicopathologic Features of Estrogen Receptor-Positive/Progesterone Receptor-Negative Breast Cancers.
    Clin Breast Cancer. 2022;22:e788-e797.
    PubMed     Abstract available
    
    
    
81. CHEVLI N, Wang K, Haque W, Schwartz MR, et al
    Prognostic Impact of Radiation Therapy in Pure Mucinous Breast Carcinoma.
    Clin Breast Cancer. 2022;22:e807-e817.
    PubMed     Abstract available
    
    
    
82. HENNESSY G, Boland MR, Bambrick M, Crone L, et al
    Value of Long-term Follow-up in Surgically Excised Lesions of Uncertain Malignant Potential in the Breast - Is 5 Years Necessary?
    Clin Breast Cancer. 2022;22:699-704.
    PubMed     Abstract available
    
    
    
83. CORADINI D, Ambrogi F
    Differential Expression of the Genes Coding for Adipokines and Epithelial Cell Polarity Components in Women With Low and High Mammographic Density.
    Clin Breast Cancer. 2022;22:715-723.
    PubMed     Abstract available
    
    
    
84. XU S, Luo W, Li M, Li Q, et al
    Circ_0001667 Promotes Adriamycin Resistance and Malignant Progression via Targeting the miR-193a-5p/Rap2A Molecular Axis in Breast Cancer.
    Clin Breast Cancer. 2022 Oct 1. pii: S1526-8209(22)00222.
    PubMed     Abstract available
    
    
    September 2022
85. VAN HOUDT M, Han SN, Pauwels S, Billen J, et al
    Measurable Serum Estradiol and Estrone in Women 36-56 Years During Adjuvant Treatment With Aromatase Inhibitors for a Hormone Receptor-Positive Breast Cancer. Case Studies and Cross-sectional Study Using an Ultra-sensitive LC-MS/MS-Method.
    Clin Breast Cancer. 2022 Sep 28. pii: S1526-8209(22)00221.
    PubMed     Abstract available
    
    
    
86. YADAV R, Kumar Y, Dahiya D, Bhatia A, et al
    Claudins: The Newly Emerging Targets in Breast Cancer.
    Clin Breast Cancer. 2022 Sep 9. pii: S1526-8209(22)00193.
    PubMed     Abstract available
    
    
    
87. SINGH J, Sangwan N, Chauhan A, Avti PK, et al
    Integrative Expression, Survival Analysis and Cellular miR-2909 Molecular Interplay in MRN Complex Check Point Sensor Genes (MRN-CSG) Involved in Breast Cancer.
    Clin Breast Cancer. 2022 Sep 9. pii: S1526-8209(22)00192.
    PubMed     Abstract available
    
    
    
88. ZHOU C, Xu L, Du Z, Lv Q, et al
    Geriatric Early-Stage Triple-Negative Breast Cancer Patients in Low-risk Population: Omitting Chemotherapy Based on Nomogram.
    Clin Breast Cancer. 2022 Sep 1. pii: S1526-8209(22)00190.
    PubMed     Abstract available
    
    
    
89. HENDRIX N, Oestreicher N, Lalla D, Dolan CM, et al
    Residual Disease Burden After Neoadjuvant Therapy Among US Patients With High-Risk HER2-positive Early-Stage Breast Cancer: A Population Effectiveness Model.
    Clin Breast Cancer. 2022 Sep 1. pii: S1526-8209(22)00189.
    PubMed     Abstract available
    
    
    August 2022
90. BARCO I, Garcia-Fdez A, Vallejo E, Tarroch X, et al
    Intraoperative Sentinel Node Fine-Needle Aspiration Biopsy as a Substitute for Whole Sentinel Node Excisional Biopsy in Breast Cancer Patients. Initial Report.
    Clin Breast Cancer. 2022 Aug 30. pii: S1526-8209(22)00185.
    PubMed     Abstract available
    
    
    
91. WONG V, de Boer R, Baron-Hay S, Blum R, et al
    Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer.
    Clin Breast Cancer. 2022 Aug 30. pii: S1526-8209(22)00188.
    PubMed     Abstract available
    
    
    
92. EDMONDS MC, Kim SJ, Wells M, Dahman B, et al
    A Mixed Method Approach to Examine Surveillance Mammography Experiences in Black and White Breast Cancer Survivors.
    Clin Breast Cancer. 2022 Aug 27. pii: S1526-8209(22)00186.
    PubMed     Abstract available
    
    
    
93. NARUI K, Miura D, Hasegawa Y, Tachibana A, et al
    A Randomized Controlled Phase 2 Study of Neoadjuvant Eribulin Versus Paclitaxel in Women with Operable Breast Cancer: The JONIE-3 Study.
    Clin Breast Cancer. 2022 Aug 22. pii: S1526-8209(22)00184.
    PubMed     Abstract available
    
    
    
94. BONADIO RC, Costa FA, Mendes SV, Araujo BJ, et al
    Disease Behavior and Treatment Response of Special Histological Types of Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2022 Aug 20. pii: S1526-8209(22)00182.
    PubMed     Abstract available
    
    
    
95. DENG SX, Castelo M, Reel E, Naganathan G, et al
    High Risk Breast Cancer Screening is a Double Edged Sword: A Qualitative Study of Patient Perspectives on the Ontario High Risk Breast Cancer Screening Program.
    Clin Breast Cancer. 2022 Aug 19. pii: S1526-8209(22)00183.
    PubMed     Abstract available
    
    
    
96. KOZAK MM, Karl J, von Eyben R, Guo F, et al
    Incidence of Brain Metastases in Women Treated With Neoadjuvant Chemotherapy for Breast Cancer: Implications for Screening.
    Clin Breast Cancer. 2022 Aug 11. pii: S1526-8209(22)00180.
    PubMed     Abstract available
    
    
    
97. SHAH S, Shaing C, Khatib J, Lodrigues W, et al
    The Utility of Breast Cancer Index (BCI) Over Clinical Prognostic Tools for Predicting the Need for Extended Endocrine Therapy: A Safety Net Hospital Experience.
    Clin Breast Cancer. 2022 Aug 11. pii: S1526-8209(22)00179.
    PubMed     Abstract available
    
    
    
98. TUGRAL A, Bakar Y, Akyol M
    The Characteristics of Pain Tolerance in Patients Who Underwent Unilateral Breast Cancer Surgery: The Effect of Handedness and Surgical Site to Assess the Potential Musculoskeletal Symptoms and Function.
    Clin Breast Cancer. 2022 Aug 6. pii: S1526-8209(22)00178.
    PubMed     Abstract available
    
    
    
99. FERNANDEZ PEREZ I, Tunas LV, Corbacho DP, Benito CG, et al
    Utility of Genomic Platforms in Treatment Decisions in Axilla-Positive Breast Cancer.
    Clin Breast Cancer. 2022 Aug 5. pii: S1526-8209(22)00176.
    PubMed     Abstract available
    
    
    
100. CHARATI FG, Shojaee L, Haghighat S, Esmaeili R, et al
     Motor Exercises Effect on Improving Shoulders Functioning, Functional Ability, Quality of Life, Depression and Anxiety For Women With Breast Cancer.
     Clin Breast Cancer. 2022 Aug 3. pii: S1526-8209(22)00171.
     PubMed     Abstract available
     
     
     
101. YEP MANZANO IS, Agrawal A
     A Comparative Study of Drain in Oncoplastic Breast Conserving Surgery (Therapeutic Mammaplasty and Chest Wall Perforator Flap Partial Breast Reconstruction) vs. Mastectomy.
     Clin Breast Cancer. 2022;22:619-627.
     PubMed     Abstract available
     
     
     
102. USLU H, Tosun M
     The benefit of superb microvascular imaging and shear wave elastography in differentiating metastatic axillary lymphadenopathy from lymphadenitis.
     Clin Breast Cancer. 2022;22:515-520.
     PubMed     Abstract available
     
     
     
103. FREBAULT J, Bergom C, Cortina CS, Shukla ME, et al
     Treatment Patterns in Women Age 80 and Over With DCIS: A Report From the National Cancer Database.
     Clin Breast Cancer. 2022;22:547-552.
     PubMed     Abstract available
     
     
     
104. SAYAN M, Kilic SS, Vergalasova I, Jan I, et al
     Risk Factors for the Development of Clinical and Subclinical Lymphedema Detected by Bioimpedance Spectroscopy.
     Clin Breast Cancer. 2022;22:553-559.
     PubMed     Abstract available
     
     
     July 2022
105. WILLIAMS AD, Solis O, Sterbling HM, Murray A, et al
     Are We Overtreating Patients With T1a HER2+ Breast Cancer? An Analysis of the National Cancer Database.
     Clin Breast Cancer. 2022 Jul 29. pii: S1526-8209(22)00175.
     PubMed     Abstract available
     
     
     
106. ALTUNDAG K
     Combination Treatment of Vinorelbine With Oral Cyclophosphamide or Capecitabine or Both Might Overcome Cross-resistance Against Eribulin in Advanced Breast Cancer.
     Clin Breast Cancer. 2022 Jul 25. pii: S1526-8209(22)00173.
     PubMed    
     
     
     
107. TUNG I, Moldovan C, Wong V, De Boer R, et al
     Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study.
     Clin Breast Cancer. 2022 Jul 14. pii: S1526-8209(22)00155.
     PubMed     Abstract available
     
     
     
108. MURCHISON S, Nichol A, Speers C, Gondara L, et al
     Locoregional Recurrence and Survival Outcomes in Breast Cancer Treated With Modern Neoadjuvant Chemotherapy: A Contemporary Population-based Analysis.
     Clin Breast Cancer. 2022 Jul 12. pii: S1526-8209(22)00145.
     PubMed     Abstract available
     
     
     
109. SHARMA A, Searle K, Hasan S, Chan S, et al
     Exclusion of Patients With Brain Metastases in Published Phase III Clinical Trials for Advanced Breast Cancer.
     Clin Breast Cancer. 2022 Jul 11. pii: S1526-8209(22)00154.
     PubMed     Abstract available
     
     
     
110. LAN B, Lv D, Sun X, Yang M, et al
     Genetic Variations in IFNGR1, BDNF and IL-10 May Predict the Susceptibility to Depression and Anxiety in Chinese Women With Breast Cancer.
     Clin Breast Cancer. 2022 Jul 9. pii: S1526-8209(22)00144.
     PubMed     Abstract available
     
     
     
111. WANG J, Li Q, Luo Y, Han Y, et al
     Development and External Validation of a Clinical Nomogram for Individually Predicting Survival of Metaplastic Breast Cancer.
     Clin Breast Cancer. 2022 Jul 9. pii: S1526-8209(22)00142.
     PubMed     Abstract available
     
     
     
112. VATHIOTIS IA, Trontzas I, Gavrielatou N, Gomatou G, et al
     Immune Checkpoint Blockade in Hormone Receptor-Positive Breast Cancer: Resistance Mechanisms and Future Perspectives.
     Clin Breast Cancer. 2022 Jul 7. pii: S1526-8209(22)00140.
     PubMed     Abstract available
     
     
     
113. MORAES MO, Forte GC, Guimaraes ADSG, Grando MBFDP, et al
     Breast MRI: Simplifying Protocol and BI-RADS Categories.
     Clin Breast Cancer. 2022;22:e615-e622.
     PubMed     Abstract available
     
     
     
114. DE VITA R, Villanucci A, Buccheri EM, Pozzi M, et al
     Extended Clinical Experience With Nipple-Sparing Mastectomy and Prepectoral Polyurethane Implant Positioning (BRAND4P method).
     Clin Breast Cancer. 2022;22:e623-e628.
     PubMed     Abstract available
     
     
     
115. MICHA A, Parvaiz MA, O'Riordan L, MacNeill F, et al
     Isotope-Only Localization for Sentinel Lymph Node Biopsy - Medium-Term Oncological Outcomes.
     Clin Breast Cancer. 2022;22:e636-e640.
     PubMed     Abstract available
     
     
     
116. XIE Y, Wang Q, Hu T, Chen R, et al
     Effect of a Novel Soaking Solution Used in Patients With Hand-Foot Syndrome as a Result of Capecitabine Treatment: A Randomized and Self-Controlled Trial.
     Clin Breast Cancer. 2022;22:e685-e690.
     PubMed     Abstract available
     
     
     
117. OMISORE AD, Odedeyi AA, Famurewa OC, Olasehinde O, et al
     Practice, Perceptions, and Prospects of Mammography Screening in Nigeria: Insights From a National Survey of Female Health Workers.
     Clin Breast Cancer. 2022;22:462-472.
     PubMed     Abstract available
     
     
     
118. TANVEER N, Dixit S, Jain P, Rani P, et al
     Static smartphone images supplemented by videoconferencing for breast telepathology.
     Clin Breast Cancer. 2022;22:455-461.
     PubMed     Abstract available
     
     
     
119. MAYROVITZ HN, Weingrad DN
     Tissue Dielectric Constant Differentials between Malignant and Benign Breast Tumors.
     Clin Breast Cancer. 2022;22:473-477.
     PubMed     Abstract available
     
     
     
120. AROLE V, Shafi S, Challa B, Parwani AV, et al
     Evaluating Mismatch Repair Status to Screen Clinical Advanced Breast Carcinomas for Immunotherapy: Experience From a Large Academic Institution.
     Clin Breast Cancer. 2022;22:e680-e684.
     PubMed     Abstract available
     
     
     
121. KELLY BN, Webster AJ, Lamb L, Spivey T, et al
     Magnetic Seeds: An Alternative to Wire Localization for Nonpalpable Breast Lesions.
     Clin Breast Cancer. 2022;22:e700-e707.
     PubMed     Abstract available
     
     
     June 2022
122. TUN SM, Alluri S, Rastegar V, Visintainer P, et al
     Mode of Detection of Second Events in Routine Surveillance of Early Stage Breast Cancer Patients.
     Clin Breast Cancer. 2022 Jun 29. pii: S1526-8209(22)00139.
     PubMed     Abstract available
     
     
     
123. MENG X, Chang X, Wang X, Guo Y, et al
     Development and Validation a Survival Prediction Model and a Risk Stratification for Elderly Locally Advanced Breast Cancer.
     Clin Breast Cancer. 2022 Jun 26. pii: S1526-8209(22)00138.
     PubMed     Abstract available
     
     
     
124. REDEMSKI T, Hamilton DG, Schuler S, Liang R, et al
     Rehabilitation for Women Undergoing Breast Cancer Surgery: A Systematic Review and Meta-Analysis of the Effectiveness of Early, Unrestricted Exercise Programs on Upper Limb Function.
     Clin Breast Cancer. 2022 Jun 24. pii: S1526-8209(22)00137.
     PubMed     Abstract available
     
     
     
125. LIU H, Mei Y, Ma X, Zhang X, et al
     FRZB is Regulated by the Transcription Factor EGR1 and Inhibits the Growth and Invasion of Triple-Negative Breast Cancer Cells by Regulating the JAK/STAT3 Pathway.
     Clin Breast Cancer. 2022 Jun 2. pii: S1526-8209(22)00115.
     PubMed     Abstract available
     
     
     
126. SHEIKH SE, Rathbone M, Chaudhary K, Joshi A, et al
     Rates and Outcomes of Breast Lesions of Uncertain Malignant Potential (B3) benchmarked against the National Breast Screening Pathology Audit; Improving Performance in a High Volume Screening Unit.
     Clin Breast Cancer. 2022;22:381-390.
     PubMed     Abstract available
     
     
     
127. VRANIC S, Gatalica Z
     An Update on the Molecular and Clinical Characteristics of Apocrine Carcinoma of the Breast.
     Clin Breast Cancer. 2022;22:e576-e585.
     PubMed     Abstract available
     
     
     
128. PETROLLA A, Hicks DG, Skinner KA, Wang X, et al
     Detailed Morphologic Evaluation of Breast Papillary Lesions on Core Biopsy Is Critical for Accurate Classification and Clinical Management: The Experience of an Academic Institute.
     Clin Breast Cancer. 2022;22:e552-e557.
     PubMed     Abstract available
     
     
     
129. GU Y, Tian J, Ran H, Ren W, et al
     Can Ultrasound Elastography Help Better Manage Mammographic BI-RADS Category 4 Breast Lesions?
     Clin Breast Cancer. 2022;22:e407-e416.
     PubMed     Abstract available
     
     
     May 2022
130. OKINES AFC, Irfan T, Mohammed K, Ring A, et al
     Vinorelbine After Prior Treatment With Eribulin for Advanced Breast Cancer: A Single-Centre Experience Suggesting Cross-Resistance.
     Clin Breast Cancer. 2022 May 27. pii: S1526-8209(22)00113.
     PubMed     Abstract available
     
     
     
131. MICELI R, Cao C, Maolanon NN, Jacobs R, et al
     Plasma Profile of Immune Determinants Predicts Pathological Complete Response in Locally Advanced Breast Cancer Patients: A Pilot Study.
     Clin Breast Cancer. 2022 May 23. pii: S1526-8209(22)00112.
     PubMed     Abstract available
     
     
     
132. HOUZARD S, Courtois E, Le Bihan Benjamin C, Erbault M, et al
     Monitoring Breast Cancer Care Quality at National and Local Level Using the French National Cancer Cohort.
     Clin Breast Cancer. 2022 May 21. pii: S1526-8209(22)00096.
     PubMed     Abstract available
     
     
     
133. MALLA R, Puvalachetty K, Vempati RK, Marni R, et al
     Cancer Stem Cells and Circulatory Tumor Cells Promote Breast Cancer Metastasis.
     Clin Breast Cancer. 2022 May 19. pii: S1526-8209(22)00094.
     PubMed     Abstract available
     
     
     
134. PATT D, Liu X, Li B, McRoy L, et al
     Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer: Flatiron Database Analysis.
     Clin Breast Cancer. 2022 May 5. pii: S1526-8209(22)00081.
     PubMed     Abstract available
     
     
     
135. POTERALA JE, Havighurst T, Braun Wisinski K
     Characterization of Weakly Hormone Receptor (HR)-Positive, HER2-Negative Breast Cancer and Current Treatment Strategies.
     Clin Breast Cancer. 2022 May 5. pii: S1526-8209(22)00080.
     PubMed     Abstract available
     
     
     April 2022
136. HEYLEN J, Punie K, Smeets A, Neven P, et al
     Elevated CA 15.3 in Newly Diagnosed Breast Cancer: A Retrospective Study.
     Clin Breast Cancer. 2022 Apr 30. pii: S1526-8209(22)00076.
     PubMed     Abstract available
     
     
     
137. TONG QY, Liu R, Gao Y, Zhang K, et al
     Effect of Electroacupuncture Based on ERAS for Preoperative Anxiety in Breast Cancer Surgery: A Single-Center, Randomized, Controlled Trial.
     Clin Breast Cancer. 2022 Apr 30. pii: S1526-8209(22)00079.
     PubMed     Abstract available
     
     
     
138. SNIDER K, Moore T, Walters C, Brachtenbach T, et al
     An Analysis of the Evidence Informing Clinical Practice Guidelines in the Management and Treatment of Breast Cancer.
     Clin Breast Cancer. 2022 Apr 29. pii: S1526-8209(22)00078.
     PubMed     Abstract available
     
     
     
139. ARIFFIN NS
     RUNX1 as a Novel Molecular Target for Breast Cancer.
     Clin Breast Cancer. 2022 Apr 26. pii: S1526-8209(22)00075.
     PubMed     Abstract available
     
     
     
140. MEHRAJ U, Alshehri B, Khan AA, Bhat AA, et al
     Expression Pattern and Prognostic Significance of Chemokines in Breast cancer: An Integrated Bioinformatics Analysis.
     Clin Breast Cancer. 2022 Apr 25. pii: S1526-8209(22)00077.
     PubMed     Abstract available
     
     
     
141. YAMADA D, Ohde S, Kajiura Y, Yagishita K, et al
     Relationship Between Breast Density, Breast Cancer Subtypes, and Prognosis.
     Clin Breast Cancer. 2022 Apr 22. pii: S1526-8209(22)00074.
     PubMed     Abstract available
     
     
     
142. VANGURI RS, Fenn KM, Kearney MR, Wang Q, et al
     Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer.
     Clin Breast Cancer. 2022 Apr 18. pii: S1526-8209(22)00071.
     PubMed     Abstract available
     
     
     
143. UDDIN MN, Wang X
     Identification of Breast Cancer Subtypes Based on Gene Expression Profiles in Breast Cancer Stroma.
     Clin Breast Cancer. 2022 Apr 5. pii: S1526-8209(22)00070.
     PubMed     Abstract available
     
     
     
144. TWELVES C, Bartsch R, Ben-Baruch NE, Borstnar S, et al
     The Place of Chemotherapy in The Evolving Treatment Landscape for Patients With HR-positive/HER2-negative MBC.
     Clin Breast Cancer. 2022;22:223-234.
     PubMed     Abstract available
     
     
     
145. SHIN HJ, Choi WJ, Park SY, Ahn SH, et al
     Prediction of Underestimation Using Contrast-Enhanced Spectral Mammography in Patients Diagnosed as Ductal Carcinoma In Situ on Preoperative Core Biopsy.
     Clin Breast Cancer. 2022;22:e374-e386.
     PubMed     Abstract available
     
     
     
146. ZENG A, Brennan ME, Young S, Mathieu E, et al
     The Effect of Supplemental Imaging on Interval Cancer Rates in Mammography Screening: Systematic Review.
     Clin Breast Cancer. 2022;22:212-222.
     PubMed     Abstract available
     
     
     
147. BRADBURY M, Hutton B, Beltran-Bless AA, Alzahrani M, et al
     Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review.
     Clin Breast Cancer. 2022;22:e362-e373.
     PubMed     Abstract available
     
     
     
148. LIN X, He Y, Fu S, Lin S, et al
     The Ultrasonographic Characteristics of Focal Fibrocystic Change of the Breast and Analysis of Misdiagnosis.
     Clin Breast Cancer. 2022;22:252-260.
     PubMed     Abstract available
     
     
     
149. LOTZ M, Ghebremichael M, Chervinsky K, Zorc T, et al
     Effective Surveillance of High-Risk Women.
     Clin Breast Cancer. 2022;22:e263-e269.
     PubMed     Abstract available
     
     
     March 2022
150. HE Y, Gao X, Wu J, Li X, et al
     Effect of Breast Conservation Therapy vs Mastectomy on Overall Survival and Breast Cancer-Specific Survival Among Men With Stage I-II Breast Cancer: Analysis of SEER, 2000-2018.
     Clin Breast Cancer. 2022 Mar 31. pii: S1526-8209(22)00069.
     PubMed     Abstract available
     
     
     
151. JACOBS W, Schagen SB, Brouwer SM, Kieffer JM, et al
     The Effects of Being Informed About Chemotherapy-Related Cognitive Symptoms With And Without Self-Affirmation on Perceived Cognitive Symptoms of Breast Cancer Patients: A Randomized Prospective, Longitudinal Study.
     Clin Breast Cancer. 2022 Mar 26. pii: S1526-8209(22)00064.
     PubMed     Abstract available
     
     
     
152. MARCZYK VR, Rosa DD, Maia AL, Goemann IM, et al
     Overall Survival for HER2-Positive Breast Cancer Patients in the HER2-Targeted Era: Evidence From a Population-Based Study.
     Clin Breast Cancer. 2022 Mar 23. pii: S1526-8209(22)00066.
     PubMed     Abstract available
     
     
     
153. JIANG C, Zhang S, Qiao K, Xiu Y, et al
     The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
     Clin Breast Cancer. 2022 Mar 21. pii: S1526-8209(22)00065.
     PubMed     Abstract available
     
     
     
154. FENG M, Yang Y, Liao W, Li Q, et al
     Margetuximab Versus Trastuzumab in Patients With Advanced Breast Cancer: A Cost-effectiveness Analysis.
     Clin Breast Cancer. 2022 Mar 17. pii: S1526-8209(22)00063.
     PubMed     Abstract available
     
     
     
155. ZHENG Y, Jiang X, Wang M, Yang S, et al
     BMPR1B Polymorphisms (rs1434536 and rs1970801) are Associated With Breast Cancer Susceptibility in Northwest Chinese Han Females: A Case-Control Study.
     Clin Breast Cancer. 2022 Mar 14. pii: S1526-8209(22)00045.
     PubMed     Abstract available
     
     
     February 2022
156. ROSSO C, Voutsadakis IA
     Characteristics, Clinical Differences and Outcomes of Breast Cancer Patients with Negative or Low HER2 Expression.
     Clin Breast Cancer. 2022 Feb 26. pii: S1526-8209(22)00042.
     PubMed     Abstract available
     
     
     
157. LIN Y, Yang Y, Zhang X, Li W, et al
     Manual Lymphatic Drainage for Breast Cancer-related Lymphedema: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
     Clin Breast Cancer. 2022 Feb 24. pii: S1526-8209(22)00034.
     PubMed     Abstract available
     
     
     
158. LI L, Xiong Y, Wang N, Zhu M, et al
     Breast Cancer Stem Cells-derived Extracellular Vesicles Affect PPARG Expression by Delivering MicroRNA-197 in Breast Cancer Cells.
     Clin Breast Cancer. 2022 Feb 11. pii: S1526-8209(22)00040.
     PubMed     Abstract available
     
     
     
159. CANINO F, Omarini C, Cerma K, Moscetti L, et al
     Ocular Toxicity in Breast Cancer Management: Manual for The Oncologist.
     Clin Breast Cancer. 2022 Feb 7. pii: S1526-8209(22)00036.
     PubMed     Abstract available
     
     
     
160. SONG Z, Li C, Zhou D, Liu J, et al
     Changes in Ki-67 in Residual Tumor and Outcome of Primary Inflammatory Breast Cancer Treated With Trimodality Therapy.
     Clin Breast Cancer. 2022 Feb 6. pii: S1526-8209(22)00035.
     PubMed     Abstract available
     
     
     
161. LIBESMAN S, Zackrisson S, Hofvind S, Seidler AL, et al
     An individual participant data meta-analysis of breast cancer detection and recall rates for digital breast tomosynthesis versus digital mammography population screening.
     Clin Breast Cancer. 2022 Feb 6. pii: S1526-8209(22)00037.
     PubMed     Abstract available
     
     
     
162. MACNAB MF, Slater G, Fuller M, Elsberger B, et al
     The Role of redo-Sentinel Lymph Node Biopsy in Patients With Prior Ipsilateral Breast Cancer Surgery.
     Clin Breast Cancer. 2022 Feb 3. pii: S1526-8209(22)00033.
     PubMed     Abstract available
     
     
     
163. FISER CK, Kronenfeld JP, Liu SN, Goel N, et al
     Comparison of Immediate Breast Reconstruction Outcomes in Patients With and Without Prior Cosmetic Breast Surgery.
     Clin Breast Cancer. 2022;22:136-142.
     PubMed     Abstract available
     
     
     
164. CHOE AI, Ismail R, Mack J, Walter V, et al
     Review of Variables Associated With Positive Surgical Margins Using Scout Reflector Localizations for Breast Conservation Therapy.
     Clin Breast Cancer. 2022;22:e232-e238.
     PubMed     Abstract available
     
     
     
165. YI M, Peng C, Xia B, Gan L, et al
     CXCL8 Facilitates the Survival and Paclitaxel-Resistance of Triple-Negative Breast Cancers.
     Clin Breast Cancer. 2022;22:e191-e198.
     PubMed     Abstract available
     
     
     
166. GUIRGUIS MS, Checka C, Adrada BE, Whitman GJ, et al
     Bracketing with Multiple Radioactive Seeds to Achieve Negative Margins in Breast Conservation Surgery: Multiple Seeds in Breast Surgery.
     Clin Breast Cancer. 2022;22:e158-e166.
     PubMed     Abstract available
     
     
     January 2022
167. HAQUE W, Verma V, Schwartz MR, Lim B, et al
     Neoadjuvant Chemotherapy for Metaplastic Breast Cancer: Response Rates, Management, and Outcomes.
     Clin Breast Cancer. 2022 Jan 31. pii: S1526-8209(22)00021.
     PubMed     Abstract available
     
     
     
168. EL-BASSIOUNY NA, Helmy MW, Hassan MAE, Khedr GA, et al
     The Cardioprotective Effect of Vitamin D in Breast Cancer Patients Receiving Adjuvant Doxorubicin Based Chemotherapy.
     Clin Breast Cancer. 2022 Jan 31. pii: S1526-8209(22)00024.
     PubMed     Abstract available
     
     
     
169. BILANI N, Ladki S, Yaghi M, Main O, et al
     Factors Associated With the Decision to Decline Chemotherapy in Patients With Early-stage, ER+/HER2- Breast Cancer and High-risk Scoring on Genomic Assays.
     Clin Breast Cancer. 2022 Jan 22. pii: S1526-8209(22)00023.
     PubMed     Abstract available
     
     
     
170. LIU J, Yu H, Cui H, Wei F, et al
     lncRNA LINC000466 Predicts the Prognosis and Promotes the Progression of Triple-negative Breast Cancer via Modulating miR-539-5p.
     Clin Breast Cancer. 2022 Jan 22. pii: S1526-8209(22)00026.
     PubMed     Abstract available
     
     
     
171. GHANBARI M, Shahinfar H, Imani H, Safabakhsh M, et al
     Association of Empirically Derived Food-Based Inflammatory Potential of the Diet and Breast Cancer: A Hospital-Based Case-Control Study.
     Clin Breast Cancer. 2022 Jan 21. pii: S1526-8209(21)00371.
     PubMed     Abstract available
     
     
     
172. ISHII T, Nakano E, Watanabe T, Higashi T, et al
     Cardiac Function Checkup During Trastuzumab Therapy Among Patients With Breast Cancer.
     Clin Breast Cancer. 2022 Jan 19. pii: S1526-8209(22)00020.
     PubMed     Abstract available
     
     
     
173. WILLIAMS AD, Ciocca R, Sabol JL, Carp NZ, et al
     The use of neoadjuvant therapy increases the rate of breast conservation in men with locally advanced breast cancer.
     Clin Breast Cancer. 2022 Jan 16. pii: S1526-8209(22)00019.
     PubMed     Abstract available
     
     
     
174. GALINDO CM, Oliveira Ganzella FA, Klassen G, Souza Ramos EA, et al
     Nuances of PFKFB3 Signaling in Breast Cancer.
     Clin Breast Cancer. 2022 Jan 15. pii: S1526-8209(22)00017.
     PubMed     Abstract available
     
     
     
175. MERFELD EC, Burr AR, Brickson C, Neuman HB, et al
     De-escalating Locoregional Therapy for Axillary Micrometastases in Breast Cancer: How Much is Too Much?
     Clin Breast Cancer. 2022 Jan 12. pii: S1526-8209(22)00016.
     PubMed     Abstract available
     
     
     
176. HADALIN V, Pislar N, Borstnar S, Matos E, et al
     Intraoperative Touch Imprint Cytology in Breast Cancer Patients After Neoadjuvant Chemotherapy.
     Clin Breast Cancer. 2022 Jan 5. pii: S1526-8209(21)00374.
     PubMed     Abstract available
     
     
     
177. OBISPO B, Rogado J, Lara Alvarez MA
     The Other Cost of the Pandemic.
     Clin Breast Cancer. 2022;22:e108.
     PubMed    
     
     
     
178. BERNINI M, Sordi S, Bembi N, Meattini I, et al
     Selective Denervation of Pectoralis Major Muscle Improves Cosmetic Outcome and Quality of Life in Retro-Pectoral Implant Based Breast Reconstruction.
     Clin Breast Cancer. 2022;22:60-66.
     PubMed     Abstract available
     
     
     
179. KANG MM, Hasan Y, Waller J, Saulsberry L, et al
     Has Hypofractionated Whole-Breast Radiation Therapy Become the Standard of Care in the United States? An Updated Report from National Cancer Database.
     Clin Breast Cancer. 2022;22:e8-e20.
     PubMed     Abstract available
     
     
     
180. WANG C, Tsang JY, Poon IK, Shao Y, et al
     An Evaluation of Clinicopathological Correlation and Outcome of Human Epidermal Growth Factor Receptor 2 Subgroups Reclassified According to the Latest ASCO/CAP Guideline.
     Clin Breast Cancer. 2022;22:e114-e122.
     PubMed     Abstract available
     
     
     
181. VARGHESE J, Gohari S, Regrag F, Rizki H, et al
     Breast Density Notification: Current UK National Practice.
     Clin Breast Cancer. 2022;22:e101-e107.
     PubMed     Abstract available
     
     
     
182. KOH J, Yoon Y, Kim S, Han K, et al
     Deep Learning for the Detection of Breast Cancers on Chest Computed Tomography.
     Clin Breast Cancer. 2022;22:26-31.
     PubMed     Abstract available
     
     
     
183. AZHAR S, Wyatt LC, Jokhakar V, Patel S, et al
     Associations between Spiritual Health Locus of Control, Perceived Discrimination and Breast and Cervical Cancer Screening for Muslim American Women in New York City.
     Clin Breast Cancer. 2022 Jan 1. pii: S1526-8209(21)00373.
     PubMed     Abstract available
     
     
     December 2021
184. WALSH EM, Mangini N, Fetting J, Armstrong D, et al
     Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes.
     Clin Breast Cancer. 2021 Dec 30. pii: S1526-8209(21)00358.
     PubMed     Abstract available
     
     
     
185. RAMOS-MARTINEZ JC, Altamirano-Gomez G, Ramos-Martinez I, Valencia J, et al
     Prognostic Value of Galectin Expression in Patients with Breast Cancer: Systematic Review and Meta-Analysis.
     Clin Breast Cancer. 2021 Dec 29. pii: S1526-8209(21)00372.
     PubMed     Abstract available
     
     
     
186. JERUSALEM G, Delea TE, Martin M, De Laurentiis M, et al
     Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR+/-HER2- Advanced Breast Cancer in the MONALEESA-3 Trial.
     Clin Breast Cancer. 2021 Dec 20. pii: S1526-8209(21)00369.
     PubMed     Abstract available
     
     
     
187. KATHURIA-PRAKASH N, Antrim L, Hornstein N, Sun AW, et al
     Factors Associated With Hospitalization Among Breast Cancer Patients With COVID-19: A Diverse Multi-Center Los Angeles Cohort Study.
     Clin Breast Cancer. 2021 Dec 17. pii: S1526-8209(21)00356.
     PubMed     Abstract available
     
     
     
188. DE GROEF A, Demeyer H, de Kinkelder C, Dukers-van Althuis S, et al
     Physical Activity Levels of Breast Cancer Patients Before Diagnosis Compared to a Reference Population: A Cross-Sectional Comparative Study.
     Clin Breast Cancer. 2021 Dec 16. pii: S1526-8209(21)00357.
     PubMed     Abstract available
     
     
     
189. SHAFAEE MN, Makawita S, Lim B, Ellis MJ, et al
     Concurrent Chemo-radiation As a Means of Achieving Pathologic Complete Response in Triple Negative Breast Cancer.
     Clin Breast Cancer. 2021 Dec 14. pii: S1526-8209(21)00352.
     PubMed     Abstract available
     
     
     
190. BIHAN-BENJAMIN CL, Bertrand C, Molinie F, Rogel A, et al
     Care pathway of women with interval breast cancer in 2016, based on medico-administrative data.
     Clin Breast Cancer. 2021 Dec 11. pii: S1526-8209(21)00353.
     PubMed     Abstract available
     
     
     
191. WANG YS, Guo R, Yang DC, Xu Y, et al
     The Interaction of NTN4 and miR-17-92 Polymorphisms on Breast Cancer Susceptibility in a Chinese Population.
     Clin Breast Cancer. 2021 Dec 10. pii: S1526-8209(21)00354.
     PubMed     Abstract available
     
     
     
192. ZOU H, Liu SH, Yang R, Wu XJ, et al
     Combination of Neutrophil-to-Lymphocyte Ratio and Red Cell Distribution Width With Serum Tumor Markers for the Differential Diagnosis of Breast Cancer and its Association With Pathological Features and Molecular Types.
     Clin Breast Cancer. 2021 Dec 3. pii: S1526-8209(21)00347.
     PubMed     Abstract available
     
     
     
193. ANGARITA FA, Jedrzejko N, Eisen D, Muraca M, et al
     Primary Care Physicians' Perspectives in Leading Breast Cancer Follow-Up Care.
     Clin Breast Cancer. 2021 Dec 2. pii: S1526-8209(21)00350.
     PubMed     Abstract available
     
     
     
194. CAPARICA R, Ma Y, De Angelis C, Richard F, et al
     Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial.
     Clin Breast Cancer. 2021 Dec 2. pii: S1526-8209(21)00351.
     PubMed     Abstract available
     
     
     
195. MACHUCA MPG, Wu WC, Yu BL, Cheng CT, et al
     Determinants of Breast-Conserving Therapy in Early-Stage Breast Cancer Patients: A Nationwide Study.
     Clin Breast Cancer. 2021 Dec 2. pii: S1526-8209(21)00344.
     PubMed     Abstract available
     
     
     
196. MAHTANI R, Oestreicher N, Lalla D, Ogbonnaya A, et al
     Health Care Resource Utilization and Costs for Metastatic Breast Cancer Patients Newly Treated with Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Agents.
     Clin Breast Cancer. 2021 Dec 2. pii: S1526-8209(21)00349.
     PubMed     Abstract available
     
     
     
197. VIUFF JH, Greiber IK, Karlsen MA, Storgaard L, et al
     Survival in Women Diagnosed With Breast Cancer During Pregnancy.
     Clin Breast Cancer. 2021 Dec 1. pii: S1526-8209(21)00346.
     PubMed     Abstract available
     
     
     
198. LIN J, Hu H, Shriver CD, Zhu K, et al
     Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program.
     Clin Breast Cancer. 2021 Dec 1. pii: S1526-8209(21)00348.
     PubMed     Abstract available
     
     
     
199. FODOR A, Brombin C, Mangili P, Tummineri R, et al
     Toxicity of Hypofractionated Whole Breast Radiotherapy Without Boost and Timescale of Late Skin Responses in a Large Cohort of Early-Stage Breast Cancer Patients.
     Clin Breast Cancer. 2021 Dec 1. pii: S1526-8209(21)00345.
     PubMed     Abstract available
     
     
     
200. HARRIS EER
     Breast Radiation and the Heart: Cardiac Toxicity and Cardiac Avoidance.
     Clin Breast Cancer. 2021;21:492-496.
     PubMed     Abstract available
     
     
     
201. GUO H, Idrovo JP, Cao J, Roychoudhury S, et al
     Human Papillomavirus (HPV) Detection by Chromogenic In Situ Hybridization (CISH) and p16 Immunohistochemistry (IHC) in Breast Intraductal Papilloma and Breast Carcinoma.
     Clin Breast Cancer. 2021;21:e638-e646.
     PubMed     Abstract available
     
     
     
202. LISA A, Losurdo A, Testori A, Tinterri C, et al
     Comment on: "Oncologic Safety of Autologous Fat Grafting in Breast Reconstruction".
     Clin Breast Cancer. 2021;21:e693.
     PubMed    
     
     
     
203. XU F, Li C, Li X, Huang Q, et al
     Competing-Risk Nomograms for Predicting the Prognosis of Patients With Infiltrating Lobular Carcinoma of the Breast.
     Clin Breast Cancer. 2021;21:e704-e714.
     PubMed     Abstract available
     
     
     
204. VAN DE VOORT EMF, Struik GM, Birnie E, Moelker A, et al
     Thermal Ablation as an Alternative for Surgical Resection of Small (
     Clin Breast Cancer. 2021;21:e715-e730.
     PubMed     Abstract available
     
     
     November 2021
205. CHIRADONI THUNGAPPA S, Maksud T, Raut N, Nagarkar R, et al
     Comparison of the Efficacy, Safety, Pharmacokinetic and Immunogenicity of UJVIRA (ZRC-3256, Trastuzumab Emtansine) With the Kadcyla (Trastuzumab Emtansine) in the Treatment of HER2-Positive Metastatic Breast Cancer: A Randomized, Open-Label, Multicent
     Clin Breast Cancer. 2021 Nov 27. pii: S1526-8209(21)00343.
     PubMed     Abstract available
     
     
     
206. MULLANGI S, Vasan N
     Genomic Characterization of De Novo Metastatic Breast Cancer.
     Clin Breast Cancer. 2021 Nov 26. pii: S1526-8209(21)00342.
     PubMed     Abstract available
     
     
     
207. AKINYEMIJU T, Oyekunle T, Salako O, Gupta A, et al
     Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND Study.
     Clin Breast Cancer. 2021 Nov 23. pii: S1526-8209(21)00320.
     PubMed     Abstract available
     
     
     
208. WOOSTER M, McGuinness JE, Fenn KM, Singh VM, et al
     Diagnosis of Leptomeningeal Metastasis in Women With Breast Cancer Through Identification of Tumor Cells in Cerebrospinal Fluid Using the CNSide Assay.
     Clin Breast Cancer. 2021 Nov 14. pii: S1526-8209(21)00318.
     PubMed     Abstract available
     
     
     
209. LI GQ, Yao J, Zhou P, Chen DX, et al
     Distribution, Chemotherapy Use, and Outcome of the 21-Gene Recurrence Score Between Chinese and White breast Cancer in the United States.
     Clin Breast Cancer. 2021 Nov 14. pii: S1526-8209(21)00319.
     PubMed     Abstract available
     
     
     
210. SHAHI S, Meza J, Tandra P, LeVan T, et al
     Gender Differences in Recommended Treatment Decisions among Breast Cancer Patients: A Study Using the National Cancer Database.
     Clin Breast Cancer. 2021 Nov 8. pii: S1526-8209(21)00307.
     PubMed     Abstract available
     
     
     
211. SILVA DTC, Vanderlei LCM, Palma MR, Ribeiro FE, et al
     Association Between Different Domains of Physical Activity and Body Adiposity Indicators in Breast Cancer Survivors.
     Clin Breast Cancer. 2021 Nov 5. pii: S1526-8209(21)00306.
     PubMed     Abstract available
     
     
     
212. KANESHIRO K, Kubo M, Taniguchi M, Yamada M, et al
     Current Status and Problems of Breast Cancer Treatment with Schizophrenia.
     Clin Breast Cancer. 2021 Nov 4. pii: S1526-8209(21)00297.
     PubMed     Abstract available
     
     
     
213. XUE M, Che S, Tian Y, Xie L, et al
     Nomogram Based on Breast MRI and Clinicopathologic Features for Predicting Axillary Lymph Node Metastasis in Patients with Early-Stage Invasive Breast Cancer: A Retrospective Study.
     Clin Breast Cancer. 2021 Nov 1. pii: S1526-8209(21)00305.
     PubMed     Abstract available
     
     
     October 2021
214. LI W, Hu S, Han Z, Jiang X, et al
     YY1-Induced Transcriptional Activation of FAM111B Contributes to the Malignancy of Breast Cancer.
     Clin Breast Cancer. 2021 Oct 29. pii: S1526-8209(21)00298.
     PubMed     Abstract available
     
     
     
215. YARDLEY DA, Young RR, Adelson KB, Silber AL, et al
     A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC).
     Clin Breast Cancer. 2021 Oct 28. pii: S1526-8209(21)00302.
     PubMed     Abstract available
     
     
     
216. BOLUKBASI Y, Oymak E, Sezen D, Onal C, et al
     Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Mono-Institutional Study: In Regard to De Matteis et al.
     Clin Breast Cancer. 2021 Oct 28. pii: S1526-8209(21)00303.
     PubMed    
     
     
     
217. MEANS-POWELL JA, Mayer IA, Ismail-Khan R, Del Valle L, et al
     A Phase Ib Dose Escalation Trial of RO4929097 (a gamma-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC).
     Clin Breast Cancer. 2021 Oct 28. pii: S1526-8209(21)00304.
     PubMed     Abstract available
     
     
     
218. MILTON L, Behroozian T, Li N, Zhang L, et al
     Symptom Burden Associated With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy.
     Clin Breast Cancer. 2021 Oct 13. pii: S1526-8209(21)00296.
     PubMed     Abstract available
     
     
     
219. MO H, Renna CE, Moore HCF, Abraham J, et al
     Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors.
     Clin Breast Cancer. 2021 Oct 9. pii: S1526-8209(21)00293.
     PubMed     Abstract available
     
     
     
220. CONTE B, Soldato D, Razeti MG, Fregatti P, et al
     De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence.
     Clin Breast Cancer. 2021 Oct 8. pii: S1526-8209(21)00292.
     PubMed     Abstract available
     
     
     
221. BENOIT L, Cambra C, Rouzier R, Cottu P, et al
     Quality of Life in an e-Cohort of Women Treated by Endocrine Therapy for Early Breast Cancer.
     Clin Breast Cancer. 2021 Oct 1. pii: S1526-8209(21)00291.
     PubMed     Abstract available
     
     
     
222. DUDLEY CM, Wiener AA, Stankowski-Drengler TJ, Schumacher JR, et al
     Rates of Ipsilateral Local-regional Recurrence in High-risk Patients Undergoing Immediate Post-mastectomy Reconstruction (AFT-01).
     Clin Breast Cancer. 2021;21:433-439.
     PubMed     Abstract available
     
     
     
223. HSIEH K, Housri N, Haffty B, Smith B, et al
     Radiation Oncologists' Views on Breast Radiation Therapy Guidelines: Utilizing an Online Q&A Platform to Assess Current Views on Whole-Breast Irradiation Therapy.
     Clin Breast Cancer. 2021;21:408-416.
     PubMed     Abstract available
     
     
     
224. DAVIS J JR, Boughey JC, Hoskin TL, Day CN, et al
     Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology.
     Clin Breast Cancer. 2021;21:458-465.
     PubMed     Abstract available
     
     
     
225. VARTHOLOMATOS G, Harissis H, Andreou M, Tatsi V, et al
     Rapid Assessment of Resection Margins During Breast Conserving Surgery Using Intraoperative Flow Cytometry.
     Clin Breast Cancer. 2021;21:e602-e610.
     PubMed     Abstract available
     
     
     
226. CARTAGENA LC, McGuire K, Zot P, Pillappa R, et al
     Breast-Conserving Surgeries With and Without Cavity Shave Margins Have Different Re-excision Rates and Associated Overall Cost: Institutional and Patient-Driven Decisions for Its Utilization.
     Clin Breast Cancer. 2021;21:e594-e601.
     PubMed     Abstract available
     
     
     
227. WU JM, Turashvili G
     A Survey of Breast Pathologists' Practice in Staging Multiple Foci of Invasive Carcinoma.
     Clin Breast Cancer. 2021;21:e506-e511.
     PubMed     Abstract available
     
     
     September 2021
228. GULER OC, Onal C
     Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients with Pathologic Negative Nodes after Neoadjuvant Chemotherapy. In regard to Schlafstein et al.
     Clin Breast Cancer. 2021 Sep 29. pii: S1526-8209(21)00288.
     PubMed    
     
     
     
229. JIA H, Zheng Y, Wang P, Wei Z, et al
     A Retrospective Study on the Clinicopathologic Characteristics and Outcomes of 179 Cases of Synchronous and Metachronous Bilateral Breast Cancer in China.
     Clin Breast Cancer. 2021 Sep 29. pii: S1526-8209(21)00289.
     PubMed     Abstract available
     
     
     
230. DE MATTEIS S, Facondo G, Valeriani M, Vullo G, et al
     Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Monoistitutional Study.
     Clin Breast Cancer. 2021 Sep 25. pii: S1526-8209(21)00266.
     PubMed     Abstract available
     
     
     
231. SEALE KN, Tkaczuk KHR
     Circulating Biomarkers in Breast Cancer.
     Clin Breast Cancer. 2021 Sep 22. pii: S1526-8209(21)00264.
     PubMed     Abstract available
     
     
     
232. JUNG L, Miske A, Indorf A, Nelson K, et al
     A Retrospective Analysis of Metronomic Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) Versus Docetaxel and Cyclophosphamide (TC) as Adjuvant Treatment in Early Stage, Hormone Receptor Positive, HER2 Negative Breast Cancer.
     Clin Breast Cancer. 2021 Sep 22. pii: S1526-8209(21)00265.
     PubMed     Abstract available
     
     
     
233. BARLUND M, Takala L, Tianen L, Kellokumpu-Lehtinen PL, et al
     Real-world Evidence of Implementing eHealth Enables Fluent Symptom-based Follow-up of a Growing Number of Patients with Breast Cancer with the Same Healthcare Resources.
     Clin Breast Cancer. 2021 Sep 20. pii: S1526-8209(21)00263.
     PubMed     Abstract available
     
     
     
234. SAKACH E, O'Regan R, Meisel J, Li X, et al
     Molecular Classification of Triple Negative Breast Cancer and the Emergence of Targeted Therapies.
     Clin Breast Cancer. 2021 Sep 17. pii: S1526-8209(21)00261.
     PubMed     Abstract available
     
     
     
235. LEVASSEUR N, Sun J, Fenton D, Baxter S, et al
     Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study.
     Clin Breast Cancer. 2021 Sep 17. pii: S1526-8209(21)00262.
     PubMed     Abstract available
     
     
     
236. LI Y, Lin Q, Lu X, Li W, et al
     Post-Diagnosis use of Antioxidant Vitamin Supplements and Breast Cancer Prognosis: A Systematic Review and Meta-Analysis.
     Clin Breast Cancer. 2021 Sep 12. pii: S1526-8209(21)00259.
     PubMed     Abstract available
     
     
     
237. RAO MALLA R, Marni R, Kumari S, Chakraborty A, et al
     Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer.
     Clin Breast Cancer. 2021 Sep 12. pii: S1526-8209(21)00260.
     PubMed     Abstract available
     
     
     August 2021
238. LI J, Li Y, Cheng H
     Circ-RPPH1 knockdown retards breast cancer progression via miR-328-3p-mediated suppression of HMGA2.
     Clin Breast Cancer. 2021 Aug 31. pii: S1526-8209(21)00247.
     PubMed     Abstract available
     
     
     
239. RIBATTI D, Annese T, Tamma R
     Controversial role of mast cells in breast cancer tumor progression and angiogenesis.
     Clin Breast Cancer. 2021 Aug 31. pii: S1526-8209(21)00246.
     PubMed     Abstract available
     
     
     
240. ZHU J, Zheng H, Ge C, Lin H, et al
     Competing Nomogram for Late-Period Breast Cancer-Specific Death in Patients with Early-Stage Hormone Receptor-Positive Breast Cancer.
     Clin Breast Cancer. 2021 Aug 31. pii: S1526-8209(21)00245.
     PubMed     Abstract available
     
     
     
241. SINCLAIR WD, Cui X
     The Effects of HER2 on CDK4/6 Activity in Breast Cancer.
     Clin Breast Cancer. 2021 Aug 26. pii: S1526-8209(21)00244.
     PubMed     Abstract available
     
     
     
242. LORUSSO P, Hamilton E, Ma C, Vidula N, et al
     A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer.
     Clin Breast Cancer. 2021 Aug 20. pii: S1526-8209(21)00240.
     PubMed     Abstract available
     
     
     
243. LI Q, Wang K, Yang L, Wu Q, et al
     Long-term Survival Comparison of Repeated Breast-conserving Surgery Versus Mastectomy for Patients with DCIS with Ipsilateral Breast Tumor Recurrence: A Real-world Longitudinal Study.
     Clin Breast Cancer. 2021;21:360-372.
     PubMed     Abstract available
     
     
     
244. HADADI I, Rae W, Clarke J, McEntee M, et al
     Diagnostic Performance of Adjunctive Imaging Modalities Compared to Mammography Alone in Women with Non-Dense and Dense Breasts: A Systematic Review and Meta-Analysis.
     Clin Breast Cancer. 2021;21:278-291.
     PubMed     Abstract available
     
     
     
245. SHAMOUN F, Asaad M, Hanson SE
     Oncologic Safety of Autologous Fat Grafting in Breast Reconstruction.
     Clin Breast Cancer. 2021;21:271-277.
     PubMed     Abstract available
     
     
     
246. SALGARELLO M, Pagliara D, Barone Adesi L, Visconti G, et al
     Direct to Implant Breast Reconstruction With Prepectoral Micropolyurethane Foam-Coated Implant: Analysis of Patient Satisfaction.
     Clin Breast Cancer. 2021;21:e454-e461.
     PubMed     Abstract available
     
     
     
247. AFSHARFARD A, Ebrahimibagha H, Zeinalpour A
     A Novel Local Transposition Flap for Lateral Breast Reconstruction After Breast Conserving Surgery.
     Clin Breast Cancer. 2021;21:e448-e453.
     PubMed     Abstract available
     
     
     
248. YAMASHITA Y, Tsunoda H, Nagura N, Kajiura Y, et al
     Long-Term Oncologic Safety of Nipple-Sparing Mastectomy With Immediate Reconstruction.
     Clin Breast Cancer. 2021;21:352-359.
     PubMed     Abstract available
     
     
     
249. MENG X, Ma H, Yin H, Yin H, et al
     Nomogram Predicting the Risk of Locoregional Recurrence After Mastectomy for Invasive Micropapillary Carcinoma of the Breast.
     Clin Breast Cancer. 2021;21:e368-e376.
     PubMed     Abstract available
     
     
     
250. GOYAL U, Saboda K, Roe D, Gonzalez VJ, et al
     Prone Positioning With Deep Inspiration Breath Hold for Left Breast Radiotherapy.
     Clin Breast Cancer. 2021;21:e295-e301.
     PubMed     Abstract available
     
     
     
251. CAPUTO GG, Zingaretti N, Kiprianidis I, Zanfisi C, et al
     Quality of Life and Early Functional Evaluation in Direct-to-Implant Breast Reconstruction After Mastectomy: A Comparative Study Between Prepectoral Versus Dual-Plane Reconstruction.
     Clin Breast Cancer. 2021;21:344-351.
     PubMed     Abstract available
     
     
     July 2021
252. TOORANG F, Sasanfar B, Esmaillzadeh A, Zendehdel K, et al
     Adherence to the DASH Diet and Risk of Breast Cancer.
     Clin Breast Cancer. 2021 Jul 31. pii: S1526-8209(21)00198.
     PubMed     Abstract available
     
     
     June 2021
253. FORTUNATO L, Loreti A, Cortese G, Spallone D, et al
     Regret and Quality of Life After Mastectomy With or Without Reconstruction.
     Clin Breast Cancer. 2021;21:162-169.
     PubMed     Abstract available
     
     
     
254. ABOUELAZAYEM M, Elkorety M, Monib S
     Breast Lymphedema After Conservative Breast Surgery: An Up-to-date Systematic Review.
     Clin Breast Cancer. 2021;21:156-161.
     PubMed     Abstract available
     
     
     
255. BRUNO E, Oliverio A, Paradiso A, Daniele A, et al
     Lifestyle Characteristics in Women Carriers of BRCA Mutations: Results From an Italian Trial Cohort.
     Clin Breast Cancer. 2021;21:e168-e176.
     PubMed     Abstract available
     
     
     
256. JAFFERBHOY SF, Goussous G, Chandarana M, Salehi-Bird S, et al
     Impact of Preoperative MRI in Invasive Ductal Carcinoma With Lobular Features on Core Biopsy.
     Clin Breast Cancer. 2021;21:e194-e198.
     PubMed     Abstract available
     
     
     
257. LONG R, Cao K, Cao M, Li XT, et al
     Improving the Diagnostic Accuracy of Breast BI-RADS 4 Microcalcification-Only Lesions Using Contrast-Enhanced Mammography.
     Clin Breast Cancer. 2021;21:256-262.
     PubMed     Abstract available
     
     
     
258. KIM H, Vargo JA, Smith KJ, Beriwal S, et al
     Cost-Effectiveness Analysis of Biological Signature DCISionRT Use for DCIS Treatment.
     Clin Breast Cancer. 2021;21:e271-e278.
     PubMed     Abstract available
     
     
     
259. DE OLIVEIRA-JUNIOR I, Brandini da Silva FC, Nazima F, Ribeiro JC Jr, et al
     Oncoplastic Surgery: Does Patient and Medical Specialty Influences the Evaluation of Cosmetic Results?
     Clin Breast Cancer. 2021;21:247-255.
     PubMed     Abstract available
     
     
     
260. NAIR NS, Chitkara G, Hawaldar RW, Parmar V, et al
     En Bloc Excision of Phyllodes Tumor of the Breast: Radical Approach Heralds Better Outcome.
     Clin Breast Cancer. 2021;21:e228-e234.
     PubMed     Abstract available
     
     
     
261. COBB AN, Janjua HM, Kuo PC
     Big Data Solutions for Controversies in Breast Cancer Treatment.
     Clin Breast Cancer. 2021;21:e199-e203.
     PubMed     Abstract available
     
     
     
262. ANDRIKOPOULOU A, Zografos E, Liontos M, Koutsoukos K, et al
     Trastuzumab Deruxtecan (DS-8201a): The Latest Research and Advances in Breast Cancer.
     Clin Breast Cancer. 2021;21:e212-e219.
     PubMed     Abstract available
     
     
     
263. BILANI N, Elson L, Liang H, Elimimian EB, et al
     Effect of Surgery at Primary and Metastatic Sites in Patients With Stage IV Breast Cancer.
     Clin Breast Cancer. 2021;21:170-180.
     PubMed     Abstract available
     
     
     
264. SUN J, Henry DA, Carr MJ, Yazdankhahkenary A, et al
     Feasibility of Axillary Lymph Node Localization and Excision Using Radar Reflector Localization.
     Clin Breast Cancer. 2021;21:e189-e193.
     PubMed     Abstract available
     
     
     April 2021
265. WISINSKI K, O'Regan R
     Introduction to Special Issue.
     Clin Breast Cancer. 2021;21:95.
     PubMed    
     
     
     
266. MONTAGNA G, Morrow M
     Breast-conserving Surgery Without Radiation Therapy for Invasive Cancer.
     Clin Breast Cancer. 2021;21:112-119.
     PubMed     Abstract available
     
     
     
267. HEPEL JT, Wazer DE
     Update on Partial Breast Irradiation.
     Clin Breast Cancer. 2021;21:96-102.
     PubMed     Abstract available
     
     
     February 2021
268. ERNST A, Flynn KE, Weil EM, Crotty BH, et al
     Aromatase Inhibitor Symptom Management Practices: A Retrospective Study.
     Clin Breast Cancer. 2021;21:e38-e47.
     PubMed     Abstract available
     
     
     
269. INUZUKA M, Watanabe C, Yokoyama S, Kuwayama T, et al
     A Retrospective Analysis of the Relationship Between the Result of BRCA1/2 Genetic Testing and Surgical Method Selection in Japan.
     Clin Breast Cancer. 2021;21:e48-e52.
     PubMed     Abstract available
     
     
     
270. SAVVA C, Sadiq M, Sheikh O, Karim S, et al
     Werner Syndrome Protein Expression in Breast Cancer.
     Clin Breast Cancer. 2021;21:57-73.
     PubMed     Abstract available
     
     
     
271. JOHN P, Osani MC, Kodali A, Buchsbaum R, et al
     Comparative Effectiveness of Adjuvant Chemotherapy in Early-Stage Breast Cancer: A Network Meta-analysis.
     Clin Breast Cancer. 2021;21:e22-e37.
     PubMed     Abstract available
     
     
     
272. MATHIAS BJ, Sun J, Sun W, Zhou JM, et al
     Surgeon Bias in the Management of Positive Sentinel Lymph Nodes.
     Clin Breast Cancer. 2021;21:74-79.
     PubMed     Abstract available
     
     
     
273. PATEL BK, Samreen N, Zhou Y, Chen J, et al
     MR Elastography of the Breast: Evolution of Technique, Case Examples, and Future Directions.
     Clin Breast Cancer. 2021;21:e102-e111.
     PubMed     Abstract available
     
     
     
274. GOFF SL, Danforth DN
     The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer.
     Clin Breast Cancer. 2021;21:e63-e73.
     PubMed     Abstract available
     
     
     
275. EARLY AP, Moon W
     Breast Cancer and Secondary Cancer Recurrences After Autologous Tissue Reconstruction.
     Clin Breast Cancer. 2021;21:e96-e101.
     PubMed     Abstract available
     
     
     
276. GADDAM S, Heller SL, Babb JS, Gao Y, et al
     Male Breast Cancer Risk Assessment and Screening Recommendations in High-Risk Men Who Undergo Genetic Counseling and Multigene Panel Testing.
     Clin Breast Cancer. 2021;21:e74-e79.
     PubMed     Abstract available
     
     
     
277. RUIZ-CASADO A, Alvarez-Bustos A, de Pedro CG, Mendez-Otero M, et al
     Cancer-related Fatigue in Breast Cancer Survivors: A Review.
     Clin Breast Cancer. 2021;21:10-25.
     PubMed     Abstract available
     
     
     
278. MCDONOUGH AL, Lei Y, Kwak AH, Haggett DE, et al
     Implementation of a Brief Screening Tool to Identify Needs of Breast Cancer Survivors.
     Clin Breast Cancer. 2021;21:e88-e95.
     PubMed     Abstract available
     
     
     
279. TUFANO AM, Teplinsky E, Landry CA
     Updates in Neoadjuvant Therapy for Triple Negative Breast Cancer.
     Clin Breast Cancer. 2021;21:1-9.
     PubMed     Abstract available
     
     
     
280. KIM DW, Kim JS, Kim K, Shin KH, et al
     Spontaneous Rib Fractures After Breast Cancer Treatment Based on Bone Scans: Comparison Of Conventional Versus Hypofractionated Radiotherapy.
     Clin Breast Cancer. 2021;21:e80-e87.
     PubMed     Abstract available
     
     
     
281. SAYAN M, Vergalasova I, Jhawar S, Kumar S, et al
     Utilization of Hypofractionated Whole-Breast Radiotherapy With Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy.
     Clin Breast Cancer. 2021;21:31-36.
     PubMed     Abstract available
     
     
     
282. PARIS I, Di Giorgio D, Carbognin L, Corrado G, et al
     Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach.
     Clin Breast Cancer. 2021;21:e120-e127.
     PubMed     Abstract available
     
     
     
283. WAN C, Williams CP, Nipp RD, Pisu M, et al
     Treatment Decision Making and Financial Toxicity in Women With Metastatic Breast Cancer.
     Clin Breast Cancer. 2021;21:37-46.
     PubMed     Abstract available
     
     
     
284. TSAI ML, Knaack M, Martone P, Krueger J, et al
     Effects of Germline Pathogenic Variants, Cancer Subtypes, Tumor-related Characteristics, and Pregnancy-associated Diagnosis on Outcomes.
     Clin Breast Cancer. 2021;21:47-56.
     PubMed     Abstract available
     
     
     
285. VILLASCO A, Agnelli F, D'Alonzo M, Accomasso F, et al
     Validation of CTS5 on a Retrospective Cohort of Real-Life Pre- and Postmenopausal Patients Diagnosed With Estrogen Receptor-Positive Breast Cancers: Is It Prognostic?
     Clin Breast Cancer. 2021;21:e53-e62.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: